ORA - Oxford University Research Archive

1 - 9 of 9

1

Journal article

CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A.

Cazares-Körner, C, Pires, IM, Swallow, ID, et al.
2013-07-05

2

Journal article

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.

Qiao, B, Kerr, M, Groselj, B, et al.
2013-03-05

3

Journal article

Mutagenesis of human DNA polymerase lambda: essential roles of Tyr505 and Phe506 for both DNA polymerase and terminal transferase activities.

Shevelev, I, Blanca, G, Villani, G, et al.
2003-12-05

4

Journal article

8-OxoA inhibits the incision of an AP site by the DNA glycosylases Fpg, Nth and the AP endonuclease HAP1.

Lomax, ME, Salje, H, Cunniffe, S, et al.
2005-01-05

5

Journal article

Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse.

Shaw, PH, Maughan, TS, Clarke, AR
2011-08-05

6

Journal article

Human DNA polymerase lambda possesses terminal deoxyribonucleotidyl transferase activity and can elongate RNA primers: implications for novel functions.

Ramadan, K, Maga, G, Shevelev, IV, et al.
2003-04-05

7

Journal article

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Byrd, JC, Brown, JR, O'Brien, S, et al.
2014-07-05

8

Journal article

Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity.

Prevo, R, Deutsch, E, Sampson, O, et al.
2008-07-05

9

Journal article

Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity.

Choudhury, A, Zhao, H, Jalali, F, et al.
2009-01-05

TO TOP